Persones / Equip Humà

Jaume Mora Graupera

Buscador de publicacions

Publicacions

  • Garzón M, García-Fructuoso G, Guillén A, Suñol M, Mora J and Cruz-Martínez O.

    Brain stem tumors in children and adolescents: single institutional experience

    CHILDS NERVOUS SYSTEM . 29(8): 1321-1331. Nº de cites: 20

    [doi:10.1007/s00381-013-2137-1]

  • Celis-Passini V, de Torres C, Parareda A, Rodriguez N, Torner-Rubies F, Cruz-Martínez O and Mora J.

    Treatment of Newly Diagnosed Ewing Sarcoma with Gemcitabine and Docetaxel as an Alternative to Conventional Therapy in 2 patients Who Did Not Wish to Undergo Intensive Chemotherapy

    Oncopedia . : 584.

  • Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, Kiezun A, Hammerman PS, McKenna A, Drier Y, Zou L, Ramos AH, Pugh TJ, Stransky N, Helman E, Kim J, Sougnez C, Ambrogio L, Nickerson E, Shefler E, Cortés ML, Auclair D, Saksena G, Voet D, Noble M, DiCara D, Lin P, Lichtenstein L, Heiman DI, Fennell T, Imielinski M, Hernandez B, Hodis E, Baca S, Dulak AM, Lohr J, Landau DA, Wu CJ, Melendez-Zajgla J, Hidalgo-Miranda A, Koren A, McCarroll SA, Mora J, Lee RS, Crompton B, Onofrio R, Parkin M, Winckler W, Ardlie K, Gabriel SB, Roberts CW, Biegel JA, Stegmaier K, Bass AJ, Garraway LA, Meyerson M, Golub TR, Gordenin DA, Sunyaev S, Lander ES and Getz G.

    Mutational heterogeneity in cancer and the search for new cancer-associated genes

    Nature . 499(7457): 214-218. Nº de cites: 4240

    [doi:10.1038/nature12213]

  • Masvidal L, Iniesta R, Casalà C, Galván P, Rodriguez E, Lavarino C, Mora J and de Torres C.

    Polymorphisms in the Calcium-Sensing Receptor Gene Are Associated with Clinical Outcome of Neuroblastoma

    PLoS One . 8(3): . Nº de cites: 13

    [doi:10.1371/journal.pone.0059762]

  • Casalà C, Gil-Guiñón E, Ordóñez JL, Miguel-Queralt S, Rodriguez E, Galván P, Lavarino C, Munell F, de Alava E, Mora J and de Torres C.

    The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis

    Carcinogenesis . 34(2): 268-276. Nº de cites: 36

    [doi:10.1093/carcin/bgs338]

  • Mora J.

    What is a pediatric tumor?

    Clinical Oncology in Adolescents and Young Adults . 2: 7-15.

    [doi:10.2147/COAYA.S29791]

  • Mayol G, Martín-Subero JI, Ríos J, Queiros A, Kulis M, Suñol M, Esteller M, Gomez-Gonzalez S, Garcia I, de Torres C, Rodriguez E, Galván P, Mora J and Lavarino C.

    DNA Hypomethylation Affects Cancer-Related Biological Functions and Genes Relevant in Neuroblastoma Pathogenesis

    PLoS One . 7(11): . Nº de cites: 33

    [doi:10.1371/journal.pone.0048401]

  • Lee RS, Stewart C, Carter SL, Ambrogio L, Cibulskis K, Sougnez C, Lawrence MS, Auclair D, Mora J, Golub TR, Biegel JA, Getz G and Roberts CW.

    A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

    JOURNAL OF CLINICAL INVESTIGATION . 122(8): 2983-2988. Nº de cites: 342

    [doi:10.1172/JCI64400]

  • Mora J, Rodriguez E, de Torres C, Cardesa-Salzmann TM, Ríos J, Hernández T, Cardesa A and de Alava E.

    Activated growth signaling pathway expression in Ewing sarcoma and clinical outcome

    PEDIATRIC BLOOD & CANCER . 58(4): 532-538. Nº de cites: 22

    [doi:10.1002/pbc.23348]

  • Garcia I, Mayol G, Ríos J, Domenech G, Cheung NK, Oberthuer A, Fischer M, Maris JM, Brodeur GM, Hero B, Rodriguez E, Suñol M, Galvan P, de Torres C, Mora J and Lavarino C.

    A Three-Gene Expression Signature Model for Risk Stratification of Patients with Neuroblastoma

    CLINICAL CANCER RESEARCH . 18(7): 2012-2023. Nº de cites: 55

    [doi:10.1158/1078-0432.CCR-11-2483]